Based on the previously constructed SP2/0-mRosa26-Lox71-GFP-Lox2272 tool cell line, we utilized the Cre-LoxP heterotypic recombination system to achieve precise site-specific substitution of the GFP expression cassette, thereby generating a stable mCherry-M22 labeled cell line. The successful cassette replacement verified that this tool cell platform enables accurate, unidirectional, and irreversible exogenous gene recombination without disrupting the endogenous genomic background. Benefiting from genetic editing at the mRosa26 genomic safe harbor locus, this system maintains stable genetic background and consistent transgene expression, effectively eliminating the defects of random integration, gene silencing and unstable expression commonly observed in traditional cell engineering.
The established mCherry-M22 cell line possesses reliable fluorescent labeling characteristics, allowing real-time visual tracking and quantitative monitoring of myeloma cell growth, proliferation and migration both in vitro and in vivo. This standardized editing platform provides a valuable tool for investigating the molecular mechanisms of myeloma progression, facilitating cell tracing analysis, and supporting functional verification of target genes. Moreover, this flexible gene replacement system can be widely applied to subsequent cell engineering modification and functional research, providing a stable and universal experimental platform for myeloma basic research and related translational studies.